A Quote by Olympia Snowe

Indeed, we must foster cost-saving competition. And that means joining the marketplace of other industrialized countries - not just for the manufacturers who sell drugs, but for consumers as well.
While American taxes pay for much of the research and development that goes into creating the new, life-saving drugs, American consumers continue to subsidize the cost of the drugs for consumers across the world.
When we call a capitalist society a consumers democracy we mean that the power to dispose of the means of production, which belongs to the entrepreneurs and capitalists, can only be acquired by means of the consumers ballot, held daily in the marketplace.
Critics of consumer capitalism like to think that consumers are manipulated and controlled by those who seek to sell them things, but for the most part it's the other way around: companies must make what consumers want and deliver it at the lowest possible price.
If consumers are strong, if consumers are protected, if they can trust the marketplace and feel confident that they're not being cheated here and there, then consumers can drive this economy forward.
I firmly believe we can bring back free and fair competition to the health care marketplace that will benefit consumers and providers alike.
[Social legislation] raised the cost of production; and what can be more illogical than to raise the cost of production in the country and then to allow the products of other countries which are not surrounded by any similar legislation, which are free from any similar cost and expenditure freely to enter our country in competition with our own goods...If these foreign goods come in cheaper, one of two things must follow...either you will take lower wages or you will lose your work.
We must put together countries that produce drugs, countries that traffic, and countries that consume, and through this multilateral effort really stop the growing of crime.
A cap and trade bill will likely increase the costs of electricity. . . . These costs will be passed on to the consumers. But the issue is, how does it actually...how do we interact in terms with the rest of the world? If other countries don't impose a cost on carbon, then we would be at a disadvantage. . . . We should look at considering duties that would offset that cost.
As more consumers demand less sugar, the food and beverage manufacturers will eventually come into line with what the consumers want.
In Europe, a product must be good, or it will not sell in competition with other products; with you, it is enough to say that it is good, often enough and sufficiently loudly. The keenest competition is not in the making of things but in the advertising of them!
Drug companies spend more on advertising and marketing than on research, more on research on lifestyle drugs than on life saving drugs, and almost nothing on diseases that affect developing countries only. This is not surprising. Poor people cannot afford drugs, and drug companies make investments that yield the highest returns.
Drug manufacturers could afford to sell AIDS drugs in Africa at virtually any discount. The companies said they did not do so because Africa lacked the requisite infrastructure.
The higher cost of getting a generic drug approved by regulators means that many old medicines don't face competitors. It's only after substantial price hikes that these drugs offer enough revenue to offset the rising generic entry costs, and start to entice competition.
When I die and go to hell, the devil is going to make me the marketing director for a cola company. I’ll be in charge of trying to sell a product that no one needs, is identical to its competition, and can’t be sold on its merits. I’d be competing head-on in the cola wars, on price, distribution, advertising, and promotion, which would indeed be hell for me. Remember, I’m the kid who couldn’t play competitive games. I’d much rather design and sell products so good and unique that they have no competition.
Light touch regulation means that we create broad regulatory frameworks that can protect consumers to ensure an overall competitive marketplace.
Industrialized countries have disproportionately more cancers than countries with little or no industry (after adjusting for age and population size). One half of all the world's cancers occur in people living in industrialized countries, even though we are only one-fifth of the world's population. Closely tracking industrialization are breast cancer rates, which are highest in North America and northern Europe, intermediate in southern Europe and Latin America, and lowest in Asia and Africa.
This site uses cookies to ensure you get the best experience. More info...
Got it!